DocDollars

Asklepios Biopharmaceutical Inc.

NC · United States · Reporting entity ID 100001341936

Total reported 2019–2025
$16.4M
#362 of 2,960 reporting companies — 0% of all reported industry payments
$16.4M in general payments across 23 records.

How it breaks down

General payments $16,372,111

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Asklepios Biopharmaceutical Inc. reported $16.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #362 of 2,960 reporting companies. All of it was general payments such as consulting, speaking, food and travel. 23 general payment records were filed.

Common questions about Asklepios Biopharmaceutical Inc.

How much has Asklepios Biopharmaceutical Inc. paid US doctors?

Asklepios Biopharmaceutical Inc. reported $16,372,111 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $16,372,111 in general payments.

How does Asklepios Biopharmaceutical Inc. rank among drug and device companies?

It ranks #362 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Asklepios Biopharmaceutical Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.